July 23rd 2025
David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
New Drug Approvals in Leukemia and Lymphoma Presented at ASH 2017
Average Profit Margin on Oncology Drugs for 340B Hospitals Nears 50%
Report Highlights Increase in Premature Deaths in the United States
FDA Announces Public Education Campaign to Encourage Smoking Cessation